Literature DB >> 14507659

Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.

Fons A J van de Loo1, Miranda B Bennink, Onno J Arntz, Ruben L Smeets, Erik Lubberts, Leo A B Joosten, Peter L E M van Lent, Christina J J Coenen-de Roo, Salvatore Cuzzocrea, Brahm H Segal, Steven M Holland, Wim B van den Berg.   

Abstract

Recent studies indicated that the nicotinamide dinucleotide phosphate oxidase (NADPH) oxidase-derived oxygen radicals plays a deleterious role in arthritis. To study this in more detail, gonarthritis was induced in NADPH oxidase-deficient mice. Mice received an intraarticular injection of either zymosan, to elicit an irritant-induced inflammation, or poly-L-lysine coupled lysozyme, to evoke an immune-complex mediated inflammation in passively immunized mice. In contrast to wild-type mice, arthritis elicited in both p47phox(-/-) and gp91(-/-) mice showed more severe joint inflammation, which developed into a granulomatous synovitis. Treatment with either Zileuton or cobra venom factor showed that the chemokines LTB4 and complement C3 were not the driving force behind the aggravated inflammation in these mice. Arthritic NADPH oxidase-deficient mice showed irreversible cartilage damage as judged by the enhanced aggrecan VDIPEN expression, and chondrocyte death. Furthermore, only in the absence of NADPH oxidase-derived oxygen radicals, the arthritic joints showed osteoclast-like cells, tartrate-resistant acid phosphatase (TRAP)-positive/multinucleated cells, extensive bone erosion, and osteolysis. The enhanced synovial gene expression of tumor necrosis factor-alpha, interleukin-1alpha, matrix metalloproteinase (MMP)-3, MMP-9 and receptor activator of NF-kappaB ligand (RANKL) might contribute to the aggravated arthritis in the NADPH oxidase-deficient mice. This showed that the involvement of NADPH oxidase in arthritis is probably far more complex and that oxygen radicals might also be important in controlling disease severity, and reducing joint inflammation and connective tissue damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507659      PMCID: PMC1868292          DOI: 10.1016/S0002-9440(10)63509-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae.

Authors:  J H Fraser; M H Helfrich; H M Wallace; S H Ralston
Journal:  Bone       Date:  1996-09       Impact factor: 4.398

2.  Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; R Hartung; H Kroeger
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

Review 3.  NADPH oxidase and the respiratory burst.

Authors:  F B Wientjes; A W Segal
Journal:  Semin Cell Biol       Date:  1995-12

4.  Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase.

Authors:  P Biemond; A J Swaak; J M Penders; C M Beindorff; J F Koster
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

5.  Tyrosine phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis.

Authors:  D Lloyds; E V Davies; B D Williams; M B Hallett
Journal:  Br J Rheumatol       Date:  1996-09

6.  Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice.

Authors:  J Schalkwijk; W B van den Berg; L B van de Putte; L A Joosten; L van den Bersselaar
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production.

Authors:  J D Pollock; D A Williams; M A Gifford; L L Li; X Du; J Fisherman; S H Orkin; C M Doerschuk; M C Dinauer
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

8.  VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.

Authors:  I I Singer; D W Kawka; E K Bayne; S A Donatelli; J R Weidner; H R Williams; J M Ayala; R A Mumford; M W Lark; T T Glant
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Phagocytosing human neutrophils inactivate their own granular enzymes.

Authors:  A A Voetman; R S Weening; M N Hamers; L J Meerhof; A A Bot; D Roos
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  The p47phox mouse knock-out model of chronic granulomatous disease.

Authors:  S H Jackson; J I Gallin; S M Holland
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  33 in total

1.  Anaplasma phagocytophilum infection induces protracted neutrophil degranulation.

Authors:  Kyoung-seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

2.  Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages.

Authors:  Souhaila Al-Khodor; Kimberly Marshall-Batty; Vinod Nair; Li Ding; David E Greenberg; Iain D C Fraser
Journal:  Cell Microbiol       Date:  2013-11-06       Impact factor: 3.715

3.  Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.

Authors:  C David Williams; Mary Lynn Bajt; Matthew R Sharpe; Mitchell R McGill; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-15       Impact factor: 4.219

4.  Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo.

Authors:  Hal X Nguyen; Aldons J Lusis; James G Tidball
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

5.  Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.

Authors:  Deborah Kienhöfer; Jonas Hahn; Julia Stoof; Janka Zsófia Csepregi; Christiane Reinwald; Vilma Urbonaviciute; Caroline Johnsson; Christian Maueröder; Malgorzata J Podolska; Mona H Biermann; Moritz Leppkes; Thomas Harrer; Malin Hultqvist; Peter Olofsson; Luis E Munoz; Attila Mocsai; Martin Herrmann; Georg Schett; Rikard Holmdahl; Markus H Hoffmann
Journal:  JCI Insight       Date:  2017-05-18

6.  Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.

Authors:  Ravindra Rajakariar; Justine Newson; Edwin K Jackson; Precilla Sawmynaden; Andrew Smith; Farooq Rahman; Muhammad M Yaqoob; Derek W Gilroy
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity.

Authors:  Wei Han; Hui Li; Jiyang Cai; Linda A Gleaves; Vasiliy V Polosukhin; Brahm H Segal; Fiona E Yull; Timothy S Blackwell
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

Review 8.  Immunometabolism and autoimmunity.

Authors:  Jenny Freitag; Luciana Berod; Thomas Kamradt; Tim Sparwasser
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

9.  NADPH oxidase limits innate immune responses in the lungs in mice.

Authors:  Brahm H Segal; Wei Han; Jennifer J Bushey; Myungsoo Joo; Zahida Bhatti; Joy Feminella; Carly G Dennis; R Robert Vethanayagam; Fiona E Yull; Maegan Capitano; Paul K Wallace; Hans Minderman; John W Christman; Michael B Sporn; Jefferson Chan; Donald C Vinh; Steven M Holland; Luigina R Romani; Sarah L Gaffen; Michael L Freeman; Timothy S Blackwell
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

10.  Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.

Authors:  Malin Hultqvist; Peter Olofsson; Jens Holmberg; B Thomas Bäckström; Jesper Tordsson; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.